Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer. - Anton A; Kamel Hasan O; Ballok Z; Bowden P; Costello AJ; Harewood L; Corcoran NM; Dundee P; Peters JS; Lawrentschuk N; Troy A; Webb D; et al. (BJU international, 2020)